HANSABIOMED LIFE SCIENCES (HBM LS) IS PARTICIPATING IN THE FOLLOWING PROJECTS

funded under H2020 from European Commission:

 

Marvel_logo_400.png

 

MARVEL

Program name: 

Coordinator: CONSIGLIO NAZIONALE DELLE RICERCHE

 

Full title/Goal:

MARVEL out-of-the-box solution is a paradigm shift from antibodies to peptides as an alternative class of affinity ligands characterized by high efficiency of EV capturing (Figure 2). In particular, MARVEL will introduce the use of membrane-sensing peptides (MSP) as novel ligands for the size-selective capturing of small EV, unbiased by differential surface protein expression (membrane as universal EV marker); in parallel, specific peptide probes (SPP) with high affinity for clinically relevant EV protein markers will be developed to enrich selective EV subpopulations. The versatility and modularity in scaling-up of the technology will be demonstrated on medium/large sample volumes in:

1) the manufacturing of GMP-compliant EV as a medicinal product for cardiac repair;

2) laboratory scale urine-based liquid biopsy for bladder cancer stratification and monitoring.

 Bow_Logo.png

BOW

Program name: FET

Coordinator:  Paolo Bergese, CSGI

 

Full Title/Goal: 

The main objective of BOW is to create hybrid magnetic nanoparticles with a membrane surface made from an extracellular vesicle. 

Within the BOW project HBM will participate in activities aimed at optimization of EV production, providing components such as EV depleted media, labelling reagents and protocols, and EV standards, as well as portable size focusing devices for SEC and TFF; Our team will contribute to comprehensive EV, and evMBDs characterization, and will ultimately verify and define minimal analytical package for definition of EV purity and quality (integrity, stability, and activity) to be assessed at each step of EV production scale up and engineering. Finally, HBM will perform in vitro tropism testing preceding definition of administration protocols for in vivo testing (doses and timeline).

 

TrainEV_400x400.jpg

 

TAIN-EV

Program name: ITN MSCA

Coordinator:  Lorraine O'Driscoll, Trinity College Dublin

 

Full Title/Goal:

 TRAINING in EXTRACELLULAR VESICLES: for benefit in Health and Disease HBM LS will evaluate and implement Costefficient high-throughput isolation methods; methods for characterizing EVs, applying bioinformatics analysis to extract biological meaning.

 

EAS

 

 

Internationalization of research and higher education, support for mobility and future generations

"Use of EVs isolated from plants of Estonian origin as natural plant protection products".

The aim of the project is to develop natural plant protection products / crop yield enhancers based on extracellular vesicles (EVs) isolated from Estonian plants.

Project no. 2014-2020.4.01.20-0303.

 

***

Product development support for the period 2014-2020

“Methods for Modification of Extracellular Vesicles (EVs) (EV-engineering)".

The aim of the project is to develop methodologies for the specific modification of extracellular vesicles (EVs) both before and after their secretion from cells. These technologies enable a company to provide services to produce EVs with specific properties that are i) tissue specific; (ii) used as carriers for medicinal products; (iii) for the calibration of instruments with specific markings.

Project no. EU60216. The cost of the project is 320,857 euros.

 

 

Program name: FET Open

Coordinator:  Paolo Bergese, Brescia University

Full Title/Goal: 

The Extracellular Vesicle Foundry Isolation and QC of high yield, high quality, QC incorporated bioprocess for EVs production in human use.